Sökning: onr:"swepub:oai:DiVA.org:hh-40796" >
The effect of ball ...
The effect of ball temperature on ball speed and carry distance in golf drives
-
- Carlsson, Magnus (författare)
- Högskolan Dalarna,Idrotts- och hälsovetenskap,Dalarna University
-
- Nilsson, Johnny, 1950- (författare)
- Gymnastik- och idrottshögskolan,Högskolan Dalarna,Idrotts- och hälsovetenskap,Laboratoriet för biomekanik och motorisk kontroll (BMC),Dalarna University
-
- Hellström, John, 1968- (författare)
- Högskolan i Halmstad,Akademin för ekonomi, teknik och naturvetenskap,The Swedish Golf Federation, Stockholm, Sweden,Svenska Golfförbundet,Halmstad University
-
visa fler...
-
- Tinmark, Fredrik (författare)
- Gymnastik- och idrottshögskolan,Laboratoriet för biomekanik och motorisk kontroll (BMC)
-
- Carlsson, Tomas (författare)
- Högskolan Dalarna,Idrotts- och hälsovetenskap,Dalarna University
-
visa färre...
-
(creator_code:org_t)
- 2018-11-28
- 2018
- Engelska.
-
Ingår i: Proceedings of the Institution of Mechanical Engineers, Part P. - London, UK : Sage Publications. - 1754-3371. ; 233:2, s. 186-192
- Relaterad länk:
-
https://urn.kb.se/re...
-
visa fler...
-
https://doi.org/10.1...
-
https://urn.kb.se/re...
-
https://urn.kb.se/re...
-
visa färre...
Abstract
Ämnesord
Stäng
- Agranulocytosis is a serious, although rare, adverse reaction to sulfasalazine, which is used to treat inflammatory joint and bowel disease. We performed a genome‐wide association study comprising 9,380,034 polymorphisms and 180 HLA alleles in 36 cases of sulfasalazine‐induced agranulocytosis and 5,170 population controls. Sulfasalazine‐induced agranulocytosis was significantly associated with the HLA region on chromosome 6. The top hit (rs9266634) was located close to HLA‐B, odds ratio (OR) 5.36 (95% confidence interval (CI) (2.97, 9.69) P = 2.55 × 10−8). We HLA‐sequenced a second cohort consisting of 40 cases and 142 treated controls, and confirmed significant associations with HLA‐B*08:01, OR = 2.25 (95% CI (1.02, 4.97) P = 0.0439), in particular the HLA‐B*08:01 haplotype HLA‐DQB1*02:01‐DRB1*03:01‐B*08:01‐C*07:01, OR = 3.79 (95% CI (1.63, 8.80) P = 0.0019), and with HLA‐A*31:01, OR = 4.81 (95% CI (1.52, 15.26) P = 0.0077). The number needed to test for HLA‐B*08:01 and HLA‐A*31:01 to avoid one case was estimated to be 1,500. We suggest that intensified monitoring or alternative treatment should be considered for known carriers of HLA‐B*08:01 or HLA‐A*31:01.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Klinisk laboratoriemedicin (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Clinical Laboratory Medicine (hsv//eng)
Nyckelord
- Klinisk farmakologi
- Clinical Pharmacology
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas